HIGHLIGHTS
- who: Xiaolei Zhang from the (UNIVERSITY) have published the research: Disease-specific variant pathogenicity prediction significantly improves variant interpretation in inherited cardiac conditions, in the Journal: (JOURNAL) of 13/Oct/2020
- what: For these reasons, while the authors show advantages of the proposed model for variant classification in known disease genes over existing genome-wide tools, the authors emphasize that CardioBoost is not intended for use as a standalone clinical decision tool, or as a replacement for the existing ACMG/ AMP guidelines for variant interpretation.
- how: The authors explored alternative models for cardiomyopathy . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.